The India Ministry of Micro, Small and Medium Enterprises announced last week a plan to provide funding to 50 universities and training institutions for the creation of up to 100 enterprise incubators within innovative fields.

 

The available pool of equity capital grew substantially last Thursday as the board of trustees for the $31.7 billion Alaska Permanent Fund approved the placement of 8 percent of the fund's value into alternative assets, such as venture capital funds and hedge funds. The Associated Press reports the current value of all alternative investments held by the Permanent Fund totals $292 million.

Southern Growth Policies Board, a regional public policy think tank, is accepting nominations for its Innovator Awards.

To support innovation and technology with increased accessibility for small-and medium-sized firms, Canada's Minister of Industry, David Emerson, announced a new program that will replace Technology Partnerships Canada (TPC).

The Economic Development Board of Bahrain and Kuwait Finance House have begun planning a $1 billion (US) Science and Technology Park in Bahrain. The park will be modeled on the Sophia Antipolis Technology Park in France, which is the largest of its kind in Europe and the second-largest technology park in the world, according to the European Commission’s PAXIS innovation program. The Kuwait Finance House has appointed Philippe Mariani, former director of the French park to oversee the new project.

 

ANGLE, an international venture management and consulting company with broad experience in technology development initiatives at the regional and national level, has position openings for a consultant and a senior executive. These starting-level positions would assist ANGLE's U.S. Consulting and Management operation on domestic and international projects. Both positions require someone with a Ph.D.

Britain’s Pre Budget Report 2005, released Dec. 5, calls for the United Kingdom to double spending for stem cell research to £100M within the next two years and launch a number of new initiatives to sustain innovation and science.

In China, leaders of the rapidly growing nation dogged by soaring energy needs and unrelenting pollution problems made a commitment to double the nation’s use of renewable energy resources within the next 15 years.

A study suggests policies enacted in 1999 to encourage cooperative research, establish tech transfer structures and provide venture capital contributed to a dramatic shift in the biotech topography in France.

While many regions, states and countries are lamenting a drain of talent from their area, the Pakistan Higher Education Commission is taking an opposite strategy to strengthen the nation's science and research capacity: sending up to 15,000 of its brightest students to study selected disciplines abroad through its Foreign Ph.D. Scholarship Program.

In the opening ceremony of the 2005 FORTUNE Global Forum, held in Beijing on May 16, Chinese President Hu Jintao broadly outlined the course his country is taking to reach a goal of quadrupling its 2000 Gross Domestic Product (GDP) by the year 2020. Science, technology and innovation figure prominently in the strategy.

Recognizing the economic benefits of engaging young people in science and technology, Ontario's McGuinty government recently launched the Youth Science and Technology Outreach Program. The new program links high school students with researchers to support in-depth mentorship experience and postsecondary career advice.

Do tax credits pave the way for more investment in R&D and equity investments in new enterprises? Or, do they reward companies and venture capitalists for investments they would have made anyway?

Discussions on these questions can become quite heated and fueled by data supportive of both sides, as two new academic analyses demonstrate.

There are several factors that go into location decisions for biomedical firms. Proximity to strong university research capacity, other biotech businesses, and technically competent workers are all important considerations. With the financial investments many states and localities are making toward the life sciences, however, the field of prospective locations for successfully launching a biotech firm has grown considerably larger than the "usual suspects."

The National Institutes of Health (NIH) data on the top 100 cities for NIH awards in FY 2003 indicates Boston reasserted its leadership over New York for the top spot by increasing its spread by $401 million. Philadelphia and Baltimore remain in third and fourth place for the second year.